2015

Bristol-Myers Squibb, UCLA enter immuno-oncology collaboration

Monday, December 14, 2015

Bristol-Myers Squibb has entered into a collaboration agreement with UCLA as part of Bristol-Myers Squibb’s Immuno-Oncology Rare Population Malignancy (I-O RPM) research program in the U.S. The I-O RPM research program is a multi-institutional initiative with academic-based cancer centers focused on the clinical investigation of immuno-oncology therapeutics as potential treatment options for patients with high risk, poor prognostic cancers, defined as a rare population malignancy.

[Read More]

Here’s how to keep patient recruitment momentum high

Monday, December 14, 2015

The Pulse on Site Success by Jeffrey Adelglass

One of the most perplexing aspects of a clinical trial is patient recruitment, as it often is difficult to find not only the desired number of subjects but also the appropriate patient population. This challenge can seem magnified during a holiday season, when many potential patients are traveling or are preoccupied with other seasonal events.

[Read More]